Trial
NCT03376659
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Georgetown University
Collaborators
Mayo Clinic; Indiana University; Emory University; National Cancer Institute (NCI); George Mason University; Thomas Jefferson University; MedImmune LLC; Bavarian Nordic
Condition
Metastatic Colorectal Cancer
Intervention
Durvalumab
Why stopped
Study closed due to lack of enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-05